Literature DB >> 30178462

Pharmacologic-Based Methods of Adherence Assessment in HIV Prevention.

Kristina M Brooks1, Peter L Anderson1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30178462      PMCID： PMC6226319          DOI： 10.1002/cpt.1201

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN： 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  11 in total

1.  Analysis of Antiretrovirals in Single Hair Strands for Evaluation of Drug Adherence with Infrared-Matrix-Assisted Laser Desorption Electrospray Ionization Mass Spectrometry Imaging.

Authors:  Elias P Rosen; Corbin G Thompson; Mark T Bokhart; Heather M A Prince; Craig Sykes; David C Muddiman; Angela D M Kashuba
Journal:  Anal Chem       Date:  2015-12-30       Impact factor: 6.986

2.  Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort study.

Authors:  Robert M Grant; Peter L Anderson; Vanessa McMahan; Albert Liu; K Rivet Amico; Megha Mehrotra; Sybil Hosek; Carlos Mosquera; Martin Casapia; Orlando Montoya; Susan Buchbinder; Valdilea G Veloso; Kenneth Mayer; Suwat Chariyalertsak; Linda-Gail Bekker; Esper G Kallas; Mauro Schechter; Juan Guanira; Lane Bushman; David N Burns; James F Rooney; David V Glidden
Journal:  Lancet Infect Dis       Date:  2014-07-22       Impact factor: 25.071

3.  Urine assay for tenofovir to monitor adherence in real time to tenofovir disoproxil fumarate/emtricitabine as pre-exposure prophylaxis.

Authors:  H C Koenig; K Mounzer; G W Daughtridge; C E Sloan; L Lalley-Chareczko; G S Moorthy; S C Conyngham; A F Zuppa; L J Montaner; P Tebas
Journal:  HIV Med       Date:  2017-04-26       Impact factor: 3.180

4.  Emtricitabine-tenofovir concentrations and pre-exposure prophylaxis efficacy in men who have sex with men.

Authors:  Peter L Anderson; David V Glidden; Albert Liu; Susan Buchbinder; Javier R Lama; Juan Vicente Guanira; Vanessa McMahan; Lane R Bushman; Martín Casapía; Orlando Montoya-Herrera; Valdilea G Veloso; Kenneth H Mayer; Suwat Chariyalertsak; Mauro Schechter; Linda-Gail Bekker; Esper Georges Kallás; Robert M Grant
Journal:  Sci Transl Med       Date:  2012-09-12       Impact factor: 17.956

5.  Single-dose pharmacokinetics and pharmacodynamics of oral tenofovir and emtricitabine in blood, saliva and rectal tissue: a sub-study of the ANRS IPERGAY trial.

Authors:  Julien Fonsart; Sentob Saragosti; Milad Taouk; Gilles Peytavin; Lane Bushman; Isabelle Charreau; Allan Hance; Lauriane Goldwirt; Stéphane Morel; Fabrizio Mammano; Bénédicte Loze; Catherine Capitant; François Clavel; Nadia Mahjoub; Laurence Meyer; Peter L Anderson; Constance Delaugerre; Jean-Michel Molina
Journal:  J Antimicrob Chemother       Date:  2016-09-28       Impact factor: 5.790

6.  Differences in Cumulative Exposure and Adherence to Tenofovir in the VOICE, iPrEx OLE, and PrEP Demo Studies as Determined via Hair Concentrations.

Authors:  Catherine A Koss; Peter Bacchetti; Sharon L Hillier; Edward Livant; Howard Horng; Nyaradzo Mgodi; Brenda G Mirembe; Kailazarid Gomez Feliciano; Stephanie Horn; Albert Y Liu; David V Glidden; Robert M Grant; Leslie Z Benet; Alexander Louie; Ariane van der Straten; Z Mike Chirenje; Jeanne M Marrazzo; Monica Gandhi
Journal:  AIDS Res Hum Retroviruses       Date:  2017-03-02       Impact factor: 2.205

7.  Plasma Tenofovir Levels to Support Adherence to TDF/FTC Preexposure Prophylaxis for HIV Prevention in MSM in Los Angeles, California.

Authors:  Raphael J Landovitz; Matthew Beymer; Ryan Kofron; Kathy Rivet Amico; Christina Psaros; Lane Bushman; Peter L Anderson; Risa Flynn; David P Lee; Robert K Bolan; Wilbert C Jordan; Chi-Hong Tseng; Rhodri Dierst-Davies; Jim Rooney; Amy Rock Wohl
Journal:  J Acquir Immune Defic Syndr       Date:  2017-12-15       Impact factor: 3.731

8.  HIV protective efficacy and correlates of tenofovir blood concentrations in a clinical trial of PrEP for HIV prevention.

Authors:  Deborah Donnell; Jared M Baeten; Namandjé N Bumpus; Justin Brantley; David R Bangsberg; Jessica E Haberer; Andrew Mujugira; Nelly Mugo; Patrick Ndase; Craig Hendrix; Connie Celum
Journal:  J Acquir Immune Defic Syndr       Date:  2014-07-01       Impact factor: 3.731

9.  Strong relationship between oral dose and tenofovir hair levels in a randomized trial: hair as a potential adherence measure for pre-exposure prophylaxis (PrEP).

Authors:  Albert Y Liu; Qiyun Yang; Yong Huang; Peter Bacchetti; Peter L Anderson; Chengshi Jin; Kathy Goggin; Kristefer Stojanovski; Robert Grant; Susan P Buchbinder; Ruth M Greenblatt; Monica Gandhi
Journal:  PLoS One       Date:  2014-01-08       Impact factor: 3.240

Review 10.  Effectiveness and safety of oral HIV preexposure prophylaxis for all populations.

Authors:  Virginia A Fonner; Sarah L Dalglish; Caitlin E Kennedy; Rachel Baggaley; Kevin R O'Reilly; Florence M Koechlin; Michelle Rodolph; Ioannis Hodges-Mameletzis; Robert M Grant
Journal:  AIDS       Date:  2016-07-31       Impact factor: 4.177
View more
  14 in total

1.  Adherence to Antiretroviral Therapy and Pre-exposure Prophylaxis: TARGETing the Ideal Measure.

Authors:  Jose R Castillo-Mancilla
Journal:  Clin Infect Dis       Date:  2020-05-06       Impact factor: 9.079

Review 2.  Point-of-care and Near Real-time Testing for Antiretroviral Adherence Monitoring to HIV Treatment and Prevention.

Authors:  Paul K Drain; Ashley R Bardon; Jane M Simoni; Tim R Cressey; Pete Anderson; Derin Sevenler; Ayokunle O Olanrewaju; Monica Gandhi; Connie Celum
Journal:  Curr HIV/AIDS Rep       Date:  2020-10       Impact factor: 5.071

3.  Study protocol of a randomized controlled trial comparing two linkage models for HIV prevention and treatment in justice-involved persons.

Authors:  Sandra A Springer; Ank E Nijhawan; Kevin Knight; Irene Kuo; Angela Di Paola; Esther Schlossberg; Cynthia A Frank; Mark Sanchez; Jennifer Pankow; Randi P Proffitt; Wayne Lehman; Zoe Pulitzer; Kelly Thompson; Sandra Violette; Kathleen K Harding
Journal:  BMC Infect Dis       Date:  2022-04-15       Impact factor: 3.667

4.  A comparison of covariate selection techniques applied to pre-exposure prophylaxis (PrEP) drug concentration data in men and transgender women at risk for HIV.

Authors:  Skyler Peterson; Mustafa Ibrahim; Peter L Anderson; Camille M Moore; Samantha MaWhinney
Journal:  J Pharmacokinet Pharmacodyn       Date:  2021-05-19       Impact factor: 2.745

5.  Point-of-Care Test for Assessing Tenofovir Adherence: Feasibility and Recommendations from Women in an Oral PrEP Program in Kenya and Their Healthcare Providers.

Authors:  Nicholas Thuo; Madison Polay; Anna M Leddy; Kenneth Ngure; Purba Chatterhee; Monica Gandhi; K Rivet Amico
Journal:  AIDS Behav       Date:  2021-04-24

6.  Using Population Pharmacokinetic Modeling to Estimate Exposure to Δ9-Tetrahydrocannabinol in an Observational Study of Cannabis Smokers in Colorado.

Authors:  Cristina Sempio; L Cinnamon Bidwell; Kent Hutchison; Marilyn A Huestis; Jost Klawitter; Uwe Christians; Thomas K Henthorn
Journal:  Ther Drug Monit       Date:  2021-08-01       Impact factor: 3.118

7.  Short Communication: A Descriptive Analysis of Dried Blood Spot Adherence Testing Among Ugandans with HIV Presenting with Cryptococcal Meningitis.

Authors:  Sarah M Lofgren; Melanie R Nicol; Tadeo K Kandole; Jose Castillo-Mancilla; Peter L Anderson; Edward Mpoza; Lillian Tugume; Ananta S Bangdiwala; Kenneth Ssebambulidde; Katherine Huppler Hullsiek; Joshua Rhein; David B Meya; David R Boulware
Journal:  AIDS Res Hum Retroviruses       Date:  2021-04-12       Impact factor: 1.723

Review 8.  Tenofovir alafenamide use in pregnant and lactating women living with HIV.

Authors:  Ahizechukwu C Eke; Kristina M Brooks; Rahel D Gebreyohannes; Jeanne S Sheffield; Kelly E Dooley; Mark Mirochnick
Journal:  Expert Opin Drug Metab Toxicol       Date:  2020-03-17       Impact factor: 4.936

9.  Comparing self-reported medication adherence measures with hair antiretroviral concentration among people living with HIV in Guangxi, China.

Authors:  Quan Zhang; Xiaoming Li; Shan Qiao; Zhiyong Shen; Yuejiao Zhou
Journal:  AIDS Res Ther       Date:  2020-03-02       Impact factor: 2.250

10.  Comparison of adherence measurement tools used in a pre-exposure prophylaxis demonstration study among female sex workers in Benin.

Authors:  Aminata Mboup; Luc Béhanzin; Fernand Guédou; Katia Giguère; Nassirou Geraldo; Djimon Marcel Zannou; René K Kêkê; Moussa Bachabi; Flore Gangbo; Dissou Affolabi; Mark A Marzinke; Craig Hendrix; Souleymane Diabaté; Michel Alary
Journal:  Medicine (Baltimore)       Date:  2020-05-22       Impact factor: 1.817
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.